Orthofix Medical Inc. revised earnings guidance for the year 2024. For the year, the company expects net sales to range between $790 million to $795 million, representing implied growth of 6% to 7% year-over-year on a constant currency basis; narrowed from previous guidance of $785 million to $795 million.